Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

This paper presents a poster presented at the 2016 World Health Organization (WHO) Conference on TB and Lung Diseases, entitled “Preventing and Combating infectious disease-related adverse events in patients with HIV/TB.”